Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Metabolomics data for Figure 1D-1F. Schofield et al, Cell Reports, "Acod1 Expression in Cancer Cells Promotes Immune Evasion through the Generation of Inhibitory Peptides"

ABSTRACT: Metabolomics raw LCMS files for Figure 1D-1F. Schofield et al, Cell Reports, "Acod1 Expression in Cancer Cells Promotes Immune Evasion through the Generation of Inhibitory Peptides".

INSTRUMENT(S): Orbitrap ID-X

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Zach Schafer

PROVIDER: MSV000094226 | MassIVE | Sun Mar 03 14:31:00 GMT 2024

SECONDARY ACCESSION(S): PXD050289

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

GNPS - Metabolomics data for Figure 1D-1F. Schofield et al, Cell Reports,

Project description:Metabolomics raw LCMS files for Figure 1D-1F. Schofield et al, Cell Reports, "Acod1 Expression in Cancer Cells Promotes Immune Evasion through the Generation of Inhibitory Peptides".

2024-03-03 | MSV000094226 | GNPS

The CD155/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer

Project description:The CD155/TIGIT axis can be co-opted during immune evasion in chronic viral infections and cancer. Pancreatic adenocarcinoma (PDAC) is a highly lethal malignancy, and immune-based strategies to combat this disease have been largely unsuccessful to date. We corroborate prior reports that a substantial portion of PDAC harbors predicted high affinity MHC class I-restricted neoepitopes and extend these findings to advanced/metastatic disease. Using two novel preclinical models of neoantigen-expressing PDAC, we demonstrate that intratumoral neoantigen-specific CD8+ T cells adopt multiple states of dysfunction, which are similar to tumor-infiltrating lymphocytes of human PDAC patients. Mechanistically, genetic and/or pharmacologic modulation of the CD155/TIGIT axis was sufficient to promote immune evasion in autochthonous neoantigen-expressing PDAC. Finally, we demonstrate that the CD155/TIGIT axis is critical to maintain immune evasion in PDAC and uncover a combination immunotherapy (TIGIT/PD-1 co-blockade plus CD40 agonism) that elicits profound anti-tumor responses in preclinical models, now poised for clinical evaluation.

2021-07-25 | GSE163059 | GEO

Acod1 Expression in Cancer Cells Promotes Immune Evasion through the Generation of Inhibitory Peptides.

Project description:Targeting PD-1 is an important component of many immune checkpoint blockade (ICB) therapeutic approaches. However, ICB is not an efficacious strategy in a variety of cancer types, in part due to immunosuppressive metabolites in the tumor microenvironment (TME). Here, we find that αPD-1-resistant cancer cells produce abundant itaconate (ITA) due to enhanced levels of aconitate decarboxylase (Acod1). Acod1 has an important role in the resistance to αPD-1, as decreasing Acod1 levels in αPD-1 resistant cancer cells can sensitize tumors to αPD-1 therapy. Mechanistically, cancer cells with high Acod1 inhibit the proliferation of naïve CD8+ T cells through the secretion of inhibitory factors. Surprisingly, inhibition of CD8+ T cell proliferation is not dependent on secretion of ITA, but is instead a consequence of the release of small inhibitory peptides. Our study suggests that strategies to counter the activity of Acod1 in cancer cells may sensitize tumors to ICB therapy.

| S-EPMC10515953 | biostudies-literature

Generation of ventralized thalamic organoids with inhibitory thalamic reticular nucleus

Project description:Generation of ventralized thalamic organoids with inhibitory thalamic reticular nucleus

| PRJNA867308 | ENA

Generation of ventralized thalamic organoids with inhibitory thalamic reticular nucleus

Project description:Generation of ventralized thalamic organoids with inhibitory thalamic reticular nucleus

| PRJNA939719 | ENA

Ptf1a promotes an inhibitory peptidergic identity in cortical pyramidal cells in vivo

Project description:Ptf1a has been shown to be necessary for determining an inhibitory interneuronal fate in many regions of the nervous system. In this study, we aim to investigate the sufficiency of Ptf1a to cell-autonomously promote a specific neuronal identity by misexpressing it in developing excitatory cortical pyramidal cells and studying its impact on pyramidal cell features, such as its gene expression profile. To accomplish this, we electroporate either a Ptf1a/GFP-misexpression construct or a GFP-only control construct into E12.5 mouse embryonic cortices, harvest the cortices at E15.5, and examine Ptf1a-induced changes to the pyramidal cell transcriptome, molecular expression pattern, neurotransmitter status, and morphology. We conclude that Ptf1a is sufficient to cell-autonomously promote an inhibitory peptidergic identity and alter neuronal morphology in developing cortical pyramidal cells. The results of this study provide insight into intrinsic transcriptional controls over neuronal identity, specifically implicate Ptf1a as a potent regulator of an inhibitory peptidergic identity, and may guide future studies of neuronal reprogramming for circuit repair after disease or injury.

2015-03-20 | GSE59481 | GEO

Inflammation-inducible promoters to overexpress immune inhibitory factors by MSCs

Project description:Inflammation-inducible promoters to overexpress immune inhibitory factors by MSCs

| PRJNA932326 | ENA

Transcriptome analysis of Candida albicans exposed to sub-inhibitory and inhibitory concentrations of tunicamycin

Project description:We exposed log phase cells of C. albicans lab strain SC5314 to sub-inhibitory (1 µg/ml) and inhibitory (4 µg/ml) of tunicamycin for 1 h, then compared the transcriptome to the no drug treated cells.

2021-05-09 | E-MTAB-10391 | biostudies-arrayexpress

Transcriptome analysis of Candida albicans exposed to sub-inhibitory and inhibitory concentrations of tunicamycin

Project description:Transcriptome analysis of Candida albicans exposed to sub-inhibitory and inhibitory concentrations of tunicamycin

| PRJEB44666 | ENA

Developmental diversification of cortical inhibitory interneurons

Project description:Developmental diversification of cortical inhibitory interneurons

| PRJNA411832 | ENA